Jan 26 eNewsletter Wow! What a course. With only the second iteration of our new Exploring Advances in the Surgical & Medical Management of Allergic & Inflammatory Disease: 2026, fondly nicknamed our Explorers Course, Dr. Villwock and the faculty kept…
Targeted Molecular Therapies in Allergy and Rhinology
AAOA’s “Targeted Molecular Therapies in Allergy and Rhinology” (Damask C. et al) was published in the Bulletin.
The past decade has seen a rapid expansion in the use of biologic drugs for the treatment of numerous chronic inflammatory diseases.
Biologic drugs are monoclonal antibodies targeting specific Type ll inflammation molecular pathways for a variety of disease entities in the head and neck.
Read the article here:




